enGene Holdings Inc. (NASDAQ:ENGNW) Short Interest Update

enGene Holdings Inc. (NASDAQ:ENGNW) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 100 shares, a drop of 50.0% from the February 28th total of 200 shares. Based on an average daily volume of 9,700 shares, the days-to-cover ratio is presently 0.0 days.

enGene Stock Down 8.8 %

Shares of NASDAQ ENGNW traded down $0.06 during trading on Friday, hitting $0.62. The company had a trading volume of 4,254 shares, compared to its average volume of 12,850. The stock has a 50 day simple moving average of $0.82 and a 200 day simple moving average of $1.23. enGene has a 12 month low of $0.42 and a 12 month high of $5.35.

About enGene

enGene Holdings Inc, through its subsidiary enGene, Inc, operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin.